search icon
lexx-img

Lexaria Bioscience Corp Share Price

LEXX
NAQ
$0.729
-$0.03
(-3.95%)
1D
Industry: Biotechnology Sector: Health Care

Lexaria Bioscience Corp Analyst Forecast

Lexaria Bioscience Corp Share Price Chart

Lexaria Bioscience Corp Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$18.88M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
68.13K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.62
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.46 L
$2.03 H
$0.729

About Lexaria Bioscience Corp, Common Stock

Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. The company's DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, epilepsy, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, and oral products; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada. more

Industry: BiotechnologySector: Health Care

Lexaria Bioscience Corp Stock Returns

Time FrameLEXXSectorS&P500
1-Week Return1.72%-1%-0.35%
1-Month Return-9.67%1.08%1.9%
3-Month Return-8.02%9.43%4.73%
6-Month Return-12.78%16.01%10.87%
1-Year Return-61.58%10.35%16.88%
3-Year Return-72.71%15.52%73.95%
5-Year Return-82.52%32.15%82.73%
10-Year Return-77.01%132.93%269.09%

Lexaria Bioscience Corp Financials

Aug '21Aug '22Aug '23Aug '24Aug '255YR TREND
Total Revenue722.74K255.40K226.21K464.28K705.92K[{"date":"2021-08-31","value":100,"profit":true},{"date":"2022-08-31","value":35.34,"profit":true},{"date":"2023-08-31","value":31.3,"profit":true},{"date":"2024-08-31","value":64.24,"profit":true},{"date":"2025-08-31","value":97.67,"profit":true}]
Cost of Revenue175.35K208.68K172.25K80.97K118.57K[{"date":"2021-08-31","value":84.03,"profit":true},{"date":"2022-08-31","value":100,"profit":true},{"date":"2023-08-31","value":82.54,"profit":true},{"date":"2024-08-31","value":38.8,"profit":true},{"date":"2025-08-31","value":56.82,"profit":true}]
Gross Profit547.39K46.71K53.96K383.30K587.35K[{"date":"2021-08-31","value":93.2,"profit":true},{"date":"2022-08-31","value":7.95,"profit":true},{"date":"2023-08-31","value":9.19,"profit":true},{"date":"2024-08-31","value":65.26,"profit":true},{"date":"2025-08-31","value":100,"profit":true}]
Gross Margin75.74%18.29%23.86%82.56%83.20%[{"date":"2021-08-31","value":91.03,"profit":true},{"date":"2022-08-31","value":21.98,"profit":true},{"date":"2023-08-31","value":28.67,"profit":true},{"date":"2024-08-31","value":99.23,"profit":true},{"date":"2025-08-31","value":100,"profit":true}]
Operating Expenses6.07M6.55M6.59M6.08M12.22M[{"date":"2021-08-31","value":49.65,"profit":true},{"date":"2022-08-31","value":53.58,"profit":true},{"date":"2023-08-31","value":53.91,"profit":true},{"date":"2024-08-31","value":49.74,"profit":true},{"date":"2025-08-31","value":100,"profit":true}]
Operating Income(5.52M)(6.50M)(6.53M)(5.70M)(11.63M)[{"date":"2021-08-31","value":-552059700,"profit":false},{"date":"2022-08-31","value":-650084400,"profit":false},{"date":"2023-08-31","value":-653402200,"profit":false},{"date":"2024-08-31","value":-569529400,"profit":false},{"date":"2025-08-31","value":-1163337300,"profit":false}]
Total Non-Operating Income/Expense-(882.81K)(135.31K)(99.05K)(275.04K)[{"date":"2021-08-31","value":"-","profit":true},{"date":"2022-08-31","value":-88280900,"profit":false},{"date":"2023-08-31","value":-13531300,"profit":false},{"date":"2024-08-31","value":-9904900,"profit":false},{"date":"2025-08-31","value":-27504400,"profit":false}]
Pre-Tax Income(4.16M)(7.38M)(6.71M)(5.81M)(11.91M)[{"date":"2021-08-31","value":-416414800,"profit":false},{"date":"2022-08-31","value":-738365300,"profit":false},{"date":"2023-08-31","value":-671252500,"profit":false},{"date":"2024-08-31","value":-580865400,"profit":false},{"date":"2025-08-31","value":-1191143400,"profit":false}]
Income Taxes(1.66M)(114.33K)130.88K--[{"date":"2021-08-31","value":-1268.25,"profit":false},{"date":"2022-08-31","value":-87.36,"profit":false},{"date":"2023-08-31","value":100,"profit":true},{"date":"2024-08-31","value":"-","profit":true},{"date":"2025-08-31","value":"-","profit":true}]
Income After Taxes-(7.27M)(6.84M)--[{"date":"2021-08-31","value":"-","profit":true},{"date":"2022-08-31","value":-726932400,"profit":false},{"date":"2023-08-31","value":-684340200,"profit":false},{"date":"2024-08-31","value":"-","profit":true},{"date":"2025-08-31","value":"-","profit":true}]
Income From Continuous Operations(4.16M)(7.38M)(6.71M)(5.81M)(11.91M)[{"date":"2021-08-31","value":-416414800,"profit":false},{"date":"2022-08-31","value":-738365300,"profit":false},{"date":"2023-08-31","value":-671252500,"profit":false},{"date":"2024-08-31","value":-580865400,"profit":false},{"date":"2025-08-31","value":-1191143400,"profit":false}]
Income From Discontinued Operations(22.00K)----[{"date":"2021-08-31","value":-2200000,"profit":false},{"date":"2022-08-31","value":"-","profit":true},{"date":"2023-08-31","value":"-","profit":true},{"date":"2024-08-31","value":"-","profit":true},{"date":"2025-08-31","value":"-","profit":true}]
Net Income(4.03M)(7.27M)(6.66M)(5.80M)(11.90M)[{"date":"2021-08-31","value":-402700600,"profit":false},{"date":"2022-08-31","value":-726932400,"profit":false},{"date":"2023-08-31","value":-666489900,"profit":false},{"date":"2024-08-31","value":-579534500,"profit":false},{"date":"2025-08-31","value":-1190184100,"profit":false}]
EPS (Diluted)(0.84)(1.25)(1.01)(0.47)(0.66)[{"date":"2021-08-31","value":-84,"profit":false},{"date":"2022-08-31","value":-125,"profit":false},{"date":"2023-08-31","value":-100.81,"profit":false},{"date":"2024-08-31","value":-47,"profit":false},{"date":"2025-08-31","value":-66,"profit":false}]

Lexaria Bioscience Corp Ratios

Lexaria Bioscience Corp Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

LEXX
Cash Ratio 3.04
Current Ratio 3.68

Lexaria Bioscience Corp Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

LEXX
ROA (LTM) -82.96%
ROE (LTM) -155.23%

Lexaria Bioscience Corp Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

LEXX
Debt Ratio Lower is generally better. Negative is bad. 0.25
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.81

Lexaria Bioscience Corp Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

LEXX
Trailing PE NM
Forward PE NM
P/S (TTM) 36.18
P/B 3.84
Price/FCF NM
EV/R 27.90
EV/Ebitda NM

FAQs

What is Lexaria Bioscience Corp share price today?

Lexaria Bioscience Corp (LEXX) share price today is $0.729

Can Indians buy Lexaria Bioscience Corp shares?

Yes, Indians can buy shares of Lexaria Bioscience Corp (LEXX) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LEXX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Lexaria Bioscience Corp be purchased?

Yes, you can purchase fractional shares of Lexaria Bioscience Corp (LEXX) via the Vested app. You can start investing in Lexaria Bioscience Corp (LEXX) with a minimum investment of $1.

How to invest in Lexaria Bioscience Corp shares from India?

You can invest in shares of Lexaria Bioscience Corp (LEXX) via Vested in three simple steps:

  • Click on Sign Up or Invest in LEXX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Lexaria Bioscience Corp shares
What is Lexaria Bioscience Corp 52-week high and low stock price?

The 52-week high price of Lexaria Bioscience Corp (LEXX) is $2.03. The 52-week low price of Lexaria Bioscience Corp (LEXX) is $0.46.

What is Lexaria Bioscience Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Lexaria Bioscience Corp (LEXX) is

What is Lexaria Bioscience Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Lexaria Bioscience Corp (LEXX) is 3.84

What is Lexaria Bioscience Corp dividend yield?

The dividend yield of Lexaria Bioscience Corp (LEXX) is 0.00%

What is the Market Cap of Lexaria Bioscience Corp?

The market capitalization of Lexaria Bioscience Corp (LEXX) is $18.88M

What is Lexaria Bioscience Corp's stock symbol?

The stock symbol (or ticker) of Lexaria Bioscience Corp is LEXX

How Can Investors Use Lexaria Bioscience Corp Share Price Data for Long-Term Investment Decisions?

Consider the share price of Lexaria Bioscience Corp as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Lexaria Bioscience Corp has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Lexaria Bioscience Corp shares for Indian investors?

When investing in Lexaria Bioscience Corp shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Lexaria Bioscience Corp stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Lexaria Bioscience Corp share price with other stocks in the same sector?

Rather than merely checking the share price of Lexaria Bioscience Corp and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Lexaria Bioscience Corp stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top